Well Health Technologies Stock Fundamentals
| WELL Stock | CAD 5.20 0.13 2.56% |
WELL Health Technologies fundamentals help investors to digest information that contributes to WELL Health's financial success or failures. It also enables traders to predict the movement of WELL Stock. The fundamental analysis module provides a way to measure WELL Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to WELL Health stock.
At this time, WELL Health's Total Operating Expenses is very stable compared to the past year. As of the 16th of March 2025, Income Before Tax is likely to grow to about 24 M, though Total Other Income Expense Net is likely to grow to (18.2 M). WELL | Select Account or Indicator |
WELL Health Technologies Company Shares Outstanding Analysis
WELL Health's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current WELL Health Shares Outstanding | 248.96 M |
Most of WELL Health's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, WELL Health Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
WELL Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for WELL Health is extremely important. It helps to project a fair market value of WELL Stock properly, considering its historical fundamentals such as Shares Outstanding. Since WELL Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of WELL Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of WELL Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
WELL Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, WELL Health Technologies has 248.96 M of shares currently outstending. This is 37.9% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The shares outstanding for all Canada stocks is 56.46% higher than that of the company.
WELL Health Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining WELL Health's current stock value. Our valuation model uses many indicators to compare WELL Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across WELL Health competition to find correlations between indicators driving WELL Health's intrinsic value. More Info.WELL Health Technologies is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.22 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for WELL Health Technologies is roughly 4.44 . At this time, WELL Health's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value WELL Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for WELL Health's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.WELL Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses WELL Health's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of WELL Health could also be used in its relative valuation, which is a method of valuing WELL Health by comparing valuation metrics of similar companies.WELL Health is currently under evaluation in shares outstanding category among its peers.
WELL Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of WELL Health from analyzing WELL Health's financial statements. These drivers represent accounts that assess WELL Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of WELL Health's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 1.1B | 937.3M | 626.8M | 910.7M | 819.6M | 860.6M | |
| Enterprise Value | 1.0B | 1.3B | 936.3M | 1.3B | 1.2B | 1.2B |
WELL Fundamentals
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0245 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 1.62 B | ||||
| Shares Outstanding | 248.96 M | ||||
| Shares Owned By Insiders | 21.18 % | ||||
| Shares Owned By Institutions | 7.09 % | ||||
| Number Of Shares Shorted | 1.85 M | ||||
| Price To Book | 1.53 X | ||||
| Price To Sales | 1.35 X | ||||
| Revenue | 776.05 M | ||||
| Gross Profit | 422.89 M | ||||
| EBITDA | 101.88 M | ||||
| Net Income | 82 K | ||||
| Cash And Equivalents | 48.91 M | ||||
| Cash Per Share | 0.25 X | ||||
| Total Debt | 426.28 M | ||||
| Debt To Equity | 0.48 % | ||||
| Current Ratio | 1.14 X | ||||
| Book Value Per Share | 3.40 X | ||||
| Cash Flow From Operations | 62.59 M | ||||
| Short Ratio | 2.14 X | ||||
| Earnings Per Share | 0.31 X | ||||
| Price To Earnings To Growth | (1.32) X | ||||
| Target Price | 8.68 | ||||
| Beta | 1.17 | ||||
| Market Capitalization | 1.29 B | ||||
| Total Asset | 1.41 B | ||||
| Retained Earnings | (63.58 M) | ||||
| Working Capital | 23.44 M | ||||
| Net Asset | 1.41 B |
About WELL Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze WELL Health Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of WELL Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of WELL Health Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 7.6 M | 8 M | |
| Total Revenue | 892.5 M | 937.1 M | |
| Cost Of Revenue | 534.2 M | 561 M | |
| Stock Based Compensation To Revenue | 0.04 | 0.04 | |
| Sales General And Administrative To Revenue | 0.32 | 0.30 | |
| Research And Ddevelopement To Revenue | 0.01 | 0.01 | |
| Capex To Revenue | 0.03 | 0.03 | |
| Revenue Per Share | 2.95 | 3.10 | |
| Ebit Per Revenue | 0.04 | 0.04 |
Other Information on Investing in WELL Stock
WELL Health financial ratios help investors to determine whether WELL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WELL with respect to the benefits of owning WELL Health security.